Related Experiment Video
Updated: Jul 20, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
Cathepsin B overexpression and lysosomal leakage in inflammatory microglia promote neuroinflammation in olfactory
Huiqin Zhou1, Li Wang2, Yuanyuan Yang2
1Department of Otolaryngology, Research Units of New Technologies of Endoscopic Surgery in Skull Base Tumor (2018RU003), Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China; ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.
Abstract:
Olfactory dysfunction (OD) is a common sensory disorder with age-related prevalence and serves as an early clinical manifestation for neurodegenerative and inflammatory diseases. Microglia in the olfactory bulb (OB) rapidly respond to olfactory injury and initiate immune responses, but the cell state dynamics and pathways driving OD remain poorly understood. Here, we performed single-cell RNA sequencing of mouse OBs at 0, 7, and 30 days post olfactory injury, and identified 3 distinct microglial states including inflammatory, negative regulatory, and homeostatic.The inflammatory microglia exacerbated neuroinflammation by secreting cytokines and chemokines that recruited immune cells and amplify local immune responses. Cathepsin B was identified as a key regulator of this inflammatory microglial activity. In vitro studies using BV2 and primary microglia demonstrated that both pharmacological inhibition and genetic deletion of CTSB attenuated lipopolysaccharide (LPS)-induced mitochondrial dysfunction, NLRP3 activation, and pro-inflammatory cytokine release. In mice with OD, pharmacological inhibition of CTSB with CA074me promoted olfactory function recovery and modulated microglial pro-inflammatory responses. Our findings uncover inflammation-associated microglial subpopulations enriched in OD and unveiled a deleterious role for CTSB-mediated neuroinflammatory signaling in OD pathogenesis. Targeting CTSB may therefore serve as a promising therapeutic strategy to mitigate microglia-mediated neuroinflammation and facilitate olfactory recovery in OD.
Insights
Olfactory dysfunction involves specific microglial states. Targeting Cathepsin B (CTSB) reduces neuroinflammation and aids olfactory recovery.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Olfactory dysfunction (OD) is common, age-related, and an early sign of neurodegenerative diseases.
- Microglia in the olfactory bulb (OB) respond to injury, but their role in OD is unclear.
- Understanding microglial dynamics is crucial for treating OD.
Purpose of the Study:
- To investigate microglial state dynamics and pathways in olfactory injury.
- To identify key regulators of microglial inflammation in OD.
- To explore therapeutic targets for OD.
Main Methods:
- Single-cell RNA sequencing of mouse OBs post-injury.
- In vitro studies on BV2 and primary microglia.
- Pharmacological inhibition of Cathepsin B (CTSB) in OD mouse models.
Main Results:
- Identified three microglial states: inflammatory, negative regulatory, and homeostatic.
- Cathepsin B (CTSB) drives inflammatory microglial activity and neuroinflammation.
- CTSB inhibition improved olfactory function and reduced microglial inflammation in OD mice.
Conclusions:
- Inflammation-associated microglial subpopulations are enriched in OD.
- CTSB plays a detrimental role in OD pathogenesis via neuroinflammation.
- Targeting CTSB offers a potential therapeutic strategy for OD.
More Related Videos
Related Concept Videos
Lysosomal Hydrolases
Parkinson Disease ll: Pathophysiology

